Defunct Company
Total Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
1,311
NCT02022540
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2014
Completion: May 31, 2016
NCT02475109
Study of Topical Ocular PAN-90806 in PDR
Start: Aug 31, 2015
Completion: Jul 31, 2016
NCT03479372
Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD
Phase: Phase 1/2
Start: Apr 26, 2018
Completion: Jun 27, 2019
NCT06536647
Contactless Assessment of Patient Vital Signs for Triage Using Remote Photoplethysmography in the Emergency Department
Phase: N/A
Role: Collaborator
Start: Sep 23, 2024
Completion: Dec 31, 2025